XBiotech Inc (XBIT) Stock Analysis

XBiotech Inc (XBIT) is a publicly traded company in the HEALTHCARE sector. It trades at $2.41, carries a market capitalization of $72.56M. This page summarizes the public market data, fundamentals, and frequently asked questions for XBIT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.41
• Market Cap: $72.56M
• EPS: $-1.31
• 52-Week High: $3.61
• 52-Week Low: $2.09

Market Sentiment

XBiotech Inc currently has a Neutral sentiment score of -0.11.

About XBiotech Inc

XBiotech Inc. is a transformative biopharmaceutical company based in Austin, Texas, specializing in the development of True Human monoclonal antibodies aimed at treating a range of diseases. Leveraging advanced technology to utilize human immune cells, the company seeks to create innovative and safer therapeutic options. With a diverse and promising pipeline, XBiotech is strategically positioned as a frontrunner in the biotherapeutics arena, committed to enhancing patient care and addressing ...

GNG Research Analysis

GNG Research scores XBiotech Inc (XBIT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for XBIT.

Frequently Asked Questions

Does XBIT pay dividends?

XBiotech Inc (XBIT) does not currently pay a regular dividend.

What is XBIT's market cap?

XBiotech Inc (XBIT) has a market capitalization of $72.56M with a current stock price of $2.41.